Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Tazarotene - Generic Drug Details

« Back to Dashboard

What are the generic sources for tazarotene and what is the scope of tazarotene patent protection?

Tazarotene
is the generic ingredient in four branded drugs marketed by Allergan, Mayne Pharma, and Taro, and is included in four NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tazarotene has twenty-nine patent family members in fifteen countries.

There are eight drug master file entries for tazarotene. Six suppliers are listed for this compound.

Summary for Generic Name: tazarotene

Tradenames:4
Patents:2
Applicants:3
NDAs:4
Drug Master File Entries: see list8
Suppliers / Packagers: see list6
Bulk Api Vendors: see list81
Clinical Trials: see list15
Patent Applications: see list5,259
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tazarotene at DailyMed

Pharmacology for Ingredient: tazarotene

Ingredient-typeRetinoids
Drug ClassRetinoid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma
FABIOR
tazarotene
AEROSOL, FOAM;TOPICAL202428-001May 11, 2012RXYesYes8,808,716► SubscribeY ► Subscribe
Allergan
TAZORAC
tazarotene
GEL;TOPICAL020600-001Jun 13, 1997RXYesYes► Subscribe► Subscribe
Allergan
AVAGE
tazarotene
CREAM;TOPICAL021184-003Sep 30, 2002ABRXYesYes► Subscribe► Subscribe
Taro
TAZAROTENE
tazarotene
CREAM;TOPICAL208258-001Apr 3, 2017ABRXNoNo► Subscribe► Subscribe
Allergan
TAZORAC
tazarotene
CREAM;TOPICAL021184-001Sep 29, 2000RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot